Corinin, Gresley, Klobuchar unfolded the bill to protect the data against the background of 23andme

First on fox: Republican Senators John Corin and Chuck Gelley and Senator -Democratic Senator Amy Klobuchar unfold a two -party measure to protect sensitive genetic data in response to privacy problems caused Bankruptcy 23andmeFox News Digital learned.

Corne, R-Texas; Gresley, R-Aowa; And Klobuchar, D-Minn., represent the “Do not sell my DNA” law, which will provide tangible customer information if the subject that supports bankruptcy files. The bill will add genetic information to the definition of “personally identified information” in the bankruptcy code.

Protect your genetic data: Urgent steps after bankruptcy 23andme

According to the current legislation, the bankruptcy code provides protection of personal information in the bankruptcy lawsuits to prevent the possibility of stealing, harm or other illegal injury.

Senate Senate said Fox News Digital that the current definition of personally identified information includes the name of the person, address, email address, phone number, social security number, credit card number and other information that can be used for identification purposes.

These assistants said the definition of “outdated” and does not include a link to genetic information, leaving information vulnerable.

Saliva’s 23ndme collection set (Kurt “Cyberguy” Knutson)

“This legislation will solve this problem by updating the definition of” personally identified information “in the bankruptcy code to include genetic information,” said the Senate Assistant.

The bill also addresses the consumer Privacy Problems With the help of consumers, the affirmatively agrees for the sale or rent of its genetic information after the bankruptcy case has begun and requiring the companies to provide a preliminary written message about the use, sale or renting of its genetic information during bankruptcy.

The bill also requires a trustee or a debtor who possesses, to remove any genetic information that is not subject to sale and rent.

Late. John Corin, R-Texas (Reuters)

“Successes in DNA testing allowed Americans to have unprecedented access to important ideas about their genetics, but these companies must have a plan to defend this data in the event of bankruptcy,” said Corin Fox News Digital.

“By updating the bankruptcy code, this legislation will provide sensitive genetic information to the Americans to make sure that it cannot be armed against them or publish them without their knowledge and consent.”

Senator Chuck Gresley, Iowa, in the US Capitol after lunch in the Senate on September 24, 2024. (Tom Williams/CQ-Roll Call, Inc via Getty Images)

And Klobuchar said the companies “received a profit from the Americans, while consumers are left in the dark, especially in light of the messages that 23ndme plans to sell customer genetic data to a large pharmaceutical company.”

“This bill will put new protection to protect the privacy of Americans, providing consumers more control over how their sensitive health data are shared,” Klobuchar said.

Gresley said digital consumers Fox News should “feel confident that any personal IThe Nformation, which has shared with the public company, will not want if this campaign falls on bankruptcy. “

Senator Amy Klobuchar, D-Minn. (Screenshot/ABC/Theview)

Grayley said Fox News Digital that the bill “would fill the blanks in the current law to help keep genetic consumer information and provide that DNA of Americans does not apply to any other financial asset.”

On Monday, 23ndme announced that Regeneron Pharmaceuticals would buy 23andme via bankruptcy auction.

The Senate Senate said that Regeneron promises to “protect consumers’ information, but data privacy for future bankruptcy remain.”

Regeneron Pharmaceuticals to purchase 23andMe bankrupt in $ 256 million

The 23andMe genetic testing company, once pioneers in consumer DNA testing, is submitted to the bankruptcy of the head 11 in March amid financial struggle, leadership and increased concern about the safety of the genetic data of its customers.

Regeneron Pharmaceuticals has announced that “virtually all” companies on genetic asset testing companies will receive.

The pharmaceutical company said he won the auction of the genetic testing campaign, refuted by the court, and Regeneron agreed to pay $ 256 million for assets. Auction for 23andme was part Section 11 bankruptcy The defense he filed in March to organize the sale of his business.

In its bankruptcy petition, the company estimated a range of $ 100 to $ 500 million for its assets. The estimated obligations were the same.

According to 23andme, Pharmaceutical buys a personal genome service and its health care and research services.